Clinical trial Recruiting at 1 site Interventional Women only

Examining the effects of prunes on bone health in postmenopausal women

Official title: Effect of Calcium and Vitamin D Supplements and/or Prunes on Bone Health

Run by San Diego State University · NCT06184646 · Data updated 2026-11-12

This study tests if eating 30 grams of prunes every day can help prevent bone loss in postmenopausal women who are also taking calcium and vitamin D supplements.

More Bone Diseases, Metabolic trials

Quick facts

Study typeInterventional
SexWomen only
Enrollment200 (estimated)
SponsorSan Diego State University
Academic / other
Drugs / interventionsprednisone
Locations1 site (San Diego, California)
StatusRecruiting
StartedMarch 15, 2024
Main results expectedDecember 2028
Study endsDecember 2028
Registry record updatedJuly 1, 2026
Trial IDNCT06184646 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are postmenopausal women with a bone mineral density t-score between 0.5 and 2 SD below the mean who are not on hormone replacement therapy or other medications affecting bone health.

Probably not a fit

Patients with a bone mineral density t-score below 2.5 SD, those on certain medications affecting bone metabolism, smokers, and regular consumers of prunes or prune juice may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates whether the consumption of 30 grams of prunes daily, alongside calcium and vitamin D supplements, can help prevent bone loss in postmenopausal women. Two hundred participants will be randomly assigned to either the prune group or a control group with no prunes, while both groups receive the same calcium and vitamin D supplementation. Blood samples will be collected at baseline, 12, and 24 months to measure biomarkers related to bone turnover, and bone mineral density will be assessed using DXA and pQCT scans at the same intervals. Additionally, participants will provide information on their physical activity and dietary habits to control for potential confounding factors.

Why it matters

Potential benefit: If successful, this study could provide a natural dietary intervention to help improve bone health in postmenopausal women.

How similar studies have gone: While the specific use of prunes for bone health is novel, other studies have shown positive effects of dietary interventions on bone health, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Postmenopausal
* BMD t-score is between 0.5 and 2 SD below the mean
* Not on hormone replacement therapy (HRT) and/or other pharmacological agents known to affect bone for at least three months prior to initiation of the study

Exclusion Criteria:

* Women whose BMD t-score at any site falls below 2.5 SD of the mean
* Subjects receiving endocrine (e.g., prednisone, other glucocorticoids) or neuroactive (e.g., dilantin, phenobarbital) drugs or any drugs known to influence bone and calcium metabolism
* Subjects who smoke cigarettes or vape
* Regular consumption of dried plum or prune juice

Where it's running

  • San Diego State University
    San Diego, California, United States
    Recruiting

Study contacts

  • Principal investigator: Shirin Hooshmand, PhD — San Diego State University
  • Study coordinator: Shirin Hooshmand, PhD
  • Email: shooshmand@sdsu.edu
  • Phone: 619-594-6823

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • How different sports affect bone metabolism in professional athletes

    We will test whether different types of physical activity change bone metabolism and related hormone and energy‑metabolism markers in healthy adult professional athletes.

    Recruiting I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Milan · NCT03386981

  • Using exosome microRNAs to identify metabolic bone disease in premature infants

    This study is trying to see if tiny particles in the blood of premature babies can help doctors spot a serious bone disease early on.

    Recruiting Hunan Children's Hospital · Changsha, Hunan · NCT06368154

  • Exploring genetic factors of primary aldosteronism in Black individuals

    This study is trying to find out how genetics affect primary aldosteronism in Black individuals with hard-to-control blood pressure to better understand the condition.

    Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT03374215

  • Evaluation of children with endocrine and metabolic conditions

    This study is testing how endocrine and metabolic disorders affect children from 3 months to 18 years old by looking at their medical history and physical exams, and it may involve family members in genetic testing to help with diagnosis.

    Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT02769975

  • CTX310 for refractory high triglycerides or LDL cholesterol

    This trial will test whether a single IV dose of CTX310 is safe and tolerated in adults whose high triglycerides or LDL cholesterol have not responded to available treatments.

    Recruiting at 16 sites Phase 1 CRISPR Therapeutics · Hialeah, Florida and 16 other locations · NCT07491172

  • Safety and tolerability of SNS851 in healthy adults.

    This study will test whether a new injectable drug called SNS851 is safe and well-tolerated when given under the skin to healthy adults aged 18 to 55.

    Recruiting Phase 1 Oneness Biotech Co., Ltd. · Melbourne · NCT07417124

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.